NAS
CLOV icon

Nykredit A/S’s Clover Health Investments CLOV Stock Holding History

Nykredit A/S’s Portfolio CLOV Stock Details CLOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$45.5K Buy
+8,682
New +$29.5K ﹤0.01% 1519

Other funds holding CLOV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Nykredit A/S's CLOV Position: Q2 2026 in Review

Nykredit A/S opened a new position in Clover Health Investments (CLOV) in Q2 2026: 8,682 shares worth $45.5K. The stake represents ﹤0.01% of the portfolio and ranks #1519 among its holdings.

166 funds tracked by Wall St. Rank hold CLOV as of Q2 2026.

  • Nykredit A/S held 8,682 shares of Clover Health Investments worth $45.5K as of Q2 2026.
  • Clover Health Investments was a new Nykredit A/S position in Q2 2026.
  • Clover Health Investments made up ﹤0.01% of Nykredit A/S's portfolio in Q2 2026, its #1519 holding.
  • 166 funds tracked by Wall St. Rank held Clover Health Investments as of Q2 2026.

Based on Nykredit A/S's 13F filing for Q2 2026, filed 13 Aug 2026.